Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
96 studies found for:    agitation and alzheimer's
Show Display Options
Rank Status Study
1 Completed
Has Results
Citalopram for Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Agitation
Interventions: Drug: citalopram;   Drug: placebo
2 Completed The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
Conditions: Alzheimer's Disease;   Agitation
Intervention:
3 Completed Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY451395;   Drug: Placebo
4 Recruiting Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Interventions: Drug: AVP-786;   Drug: Placebo
5 Recruiting Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Interventions: Drug: AVP-786;   Drug: Placebo
6 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
7 Not yet recruiting Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Gabapentin Enacarbil;   Drug: Placebo Oral Tablet
8 Recruiting ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
Condition: Agitation in Dementia, Including Alzheimer's Disease
Interventions: Drug: ITI-007;   Drug: Placebo
9 Completed
Has Results
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ELND005;   Drug: Placebo
10 Completed
Has Results
Alzheimer's in Long-Term Care--Treatment for Agitation
Conditions: Alzheimer Disease;   Psychomotor Agitation
Interventions: Drug: prazosin;   Drug: placebo (inert substance)
11 Completed Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
12 Recruiting Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ORM-12741;   Drug: Placebo
13 Recruiting Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
Condition: Agitation Associated With Dementia of the Alzheimer's Type
Interventions: Drug: 2 mg/day;   Drug: 3 mg/day;   Drug: 6 mg/day;   Drug: Placebo (0 mg/day)
14 Completed Effects of Light-therapy in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Other: Luxtherapy
15 Recruiting Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Condition: Agitation and Aggression in Alzheimer's Disease
Interventions: Drug: Pimavanserin 34 mg;   Drug: Pimavanserin 20 mg;   Other: Placebo
16 Active, not recruiting A Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
17 Not yet recruiting Escitalopram for Agitation in Alzheimer's Disease
Condition: Dementia
Interventions: Drug: Escitalopram;   Drug: Placebo
18 Active, not recruiting Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
19 Recruiting Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD)
Condition: Alzheimer's Disease
Interventions: Drug: Dronabinol (Marinol®);   Drug: Placebo
20 Completed An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.